Disease

CFHR1 associated susceptibility to atypical hemolytic uremic syndrome (CFH/CFHR1 hybrid allele, CFHR1/CFH hybrid allele, CFHR1/CFHR4 deletion, CFHR3/CFHR1 deletion)1, 2

Gene

CFHR1

Inheritance AR and AD
Current Treatments Eculizumab, Ravulizumab, Plasma infusion or exchange
Evidence for Treatment guideline3
Non-Molecular Testing Availability no
Disease Frequency (per 100,000) 0.24
Genes Included in Disease Frequency C3, CFH, CFI, THBD, CD46, CFB, CFHR1
Experimental / Investigational Therapies https://clinicaltrials.gov/ct2/results?cond=Atypical+Hemolytic+Uremic+Syndrome&term=&cntry=&state=&city=&dist=
Last Updated: March 5, 2026
RX Genes
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.